galantamine HBr

DRUG2 trials

Sponsors

Massachusetts General Hospital, Xian-Janssen Pharmaceutical Ltd.

Conditions

ADHDAlzheimer Disease

Phase 3

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

CompletedNCT00645190

Xian-Janssen Pharmaceutical Ltd.Alzheimer Disease

Start: 2004-03-31End: 2005-02-28Updated: 2011-05-19

Phase 4

A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder

CompletedNCT00181675

Massachusetts General HospitalADHD

Start: 2002-12-31End: 2003-09-30Target: 40Updated: 2010-07-23